Search
Add Trial
Sign In
Sponsor Name
Tumor Site NSCLC - Non Small Cell Lung Cancer
Disease Stage Stage I, Stage II, Stage III
Clinical Status Adjuvant, Operable
Phase Phase III
Intervention / Treatment Durvalumab versus Placebo
Research Site Quebec, Quebec Heart and Lung Institute
Investigator Dre Lise Tremblay
Telephone Number +1 418 656-8711
Study Start Date October 9, 2014
Study End Date January 1, 2023
Trial Status Recruitment

Tags

Working Hours :

Now Closed UTC - 5
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialité, n'incluez pas le nom du patient

Hosted by :

Claim listing: CCTG BR.31

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message

Sign In KANCEL

Please select an account type above.

Account details will be confirmed via email.

Register with us by filling out the form below.
Register with us by filling out the form below.

Reset Your Password